Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · IEX Real-Time Price · USD
191.46
-13.19 (-6.45%)
Apr 25, 2024, 11:45 AM EDT - Market open

Madrigal Pharmaceuticals Statistics

Total Valuation

MDGL has a market cap or net worth of $4.00 billion. The enterprise value is $3.78 billion.

Market Cap 4.00B
Enterprise Value 3.78B

Important Dates

The next confirmed earnings date is Tuesday, May 7, 2024, before market open.

Earnings Date May 7, 2024
Ex-Dividend Date n/a

Share Statistics

MDGL has 20.99 million shares outstanding. The number of shares has increased by 9.05% in one year.

Shares Outstanding 20.99M
Shares Change (YoY) +9.05%
Shares Change (QoQ) +7.02%
Owned by Insiders (%) 9.24%
Owned by Institutions (%) 94.86%
Float 12.78M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 10.60
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.38, with a Debt / Equity ratio of 0.29.

Current Ratio 5.38
Quick Ratio n/a
Debt / Equity 0.29
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -28.39

Financial Efficiency

Return on equity (ROE) is -219.40% and return on invested capital (ROIC) is -72.82%.

Return on Equity (ROE) -219.40%
Return on Assets (ROA) -98.80%
Return on Capital (ROIC) -72.82%
Revenue Per Employee n/a
Profits Per Employee -$993,697
Employee Count 376
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.88% in the last 52 weeks. The beta is -0.44, so MDGL's price volatility has been lower than the market average.

Beta (1Y) -0.44
52-Week Price Change -34.88%
50-Day Moving Average 242.85
200-Day Moving Average 201.69
Relative Strength Index (RSI) 28.35
Average Volume (30 Days) 589,532

Short Selling Information

The latest short interest is 3.36 million, so 16.02% of the outstanding shares have been sold short.

Short Interest 3.36M
Short Previous Month 3.26M
Short % of Shares Out 16.02%
Short % of Float 26.32%
Short Ratio (days to cover) 4.79

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -380.50M
Pretax Income -373.63M
Net Income -373.63M
EBITDA -360.39M
EBIT -360.92M
Earnings Per Share (EPS) -$19.99
Full Income Statement

Balance Sheet

The company has $634.13 million in cash and $117.19 million in debt, giving a net cash position of $516.94 million or $24.62 per share.

Cash & Cash Equivalents 634.13M
Total Debt 117.19M
Net Cash 516.94M
Net Cash Per Share $24.62
Equity / Book Value 405.33M
Book Value Per Share 19.31
Working Capital 518.73M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$324.23 million and capital expenditures -$1.48 million, giving a free cash flow of -$325.71 million.

Operating Cash Flow -324.23M
Capital Expenditures -1.48M
Free Cash Flow -325.71M
FCF Per Share -$17.43
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MDGL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.05%
Shareholder Yield -9.05%
Earnings Yield -8.70%
FCF Yield -7.58%
Dividend Details

Analyst Forecast

The average price target for MDGL is $355.36, which is 85.61% higher than the current price. The consensus rating is "Buy".

Price Target $355.36
Price Target Difference 85.61%
Analyst Consensus Buy
Analyst Count 12
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 25, 2016. It was a reverse split with a ratio of 1:35.

Last Split Date Jul 25, 2016
Split Type Reverse
Split Ratio 1:35

Scores

Altman Z-Score n/a
Piotroski F-Score 2